PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.\', \'Genome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.\', \'School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.\', \'Department of Laboratory Medicine, National University Hospital, National University Health System, Singapore, Singapore.\', \'School of Computer Science and Engineering, Nanyang Technological University, Singapore, Singapore.\', \'Bioinformatics Institute, Agency for Science Technology and Research, Singapore, Singapore.\', \'Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.\', \'School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore. mh.tan@ntu.edu.sg.\', \'Genome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore. mh.tan@ntu.edu.sg.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-21996-6
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33741959
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33741959>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33741959>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all